ALZAMEND NEURO, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
ALZAMEND NEURO, INC. (ALZN) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 1.59 million shares as of 2026-07-31, per its 10-Q filed 2026-09-10.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2026-09-10
- 2026-07-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 1.59M shares.
- 2026-04-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 1.59M shares.
- 2025-07-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 9.41K shares.
- 2025-04-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 9.41K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed |
|---|---|---|
| 2026-07-31 | 1.59M shares 10-Q · filed 2026-09-10 | |
| 2026-04-30 | 1.59M shares 10-Q · filed 2026-09-10 | |
| 2025-07-31 | 9.41K shares 10-Q · filed 2025-09-10 | |
| 2025-04-30 | 9.41K shares 10-K · filed 2026-07-22 | |
| 2025-01-31 | 94.67K shares 10-Q · filed 2025-03-10 | |
| 2024-10-31 | 94.67K shares 10-Q · filed 2024-12-11 | |
| 2024-07-31 | 94.67K shares 10-Q · filed 2024-09-11 | |
| 2024-04-30 | 10.89K shares 10-K · filed 2025-07-22 | 98.00K shares 10-K · filed 2024-07-30 |
| 2024-01-31 | 980.00K shares 10-Q · filed 2024-03-25 | |
| 2023-10-31 | 980.00K shares 10-Q · filed 2023-12-15 | |
| 2023-07-31 | 14.81M shares 10-Q · filed 2023-09-13 | |
| 2023-04-30 | 98.72K shares 10-K · filed 2024-07-30 | 14.81M shares 10-K · filed 2023-07-27 |
| 2023-01-31 | 15.31M shares 10-Q · filed 2023-03-15 | |
| 2022-10-31 | 14.31M shares 10-Q · filed 2022-12-12 | |
| 2022-07-31 | 14.60M shares 10-Q · filed 2022-09-13 | |
| 2022-04-30 | 15.70M shares 10-K · filed 2023-07-27 | |
| 2022-01-31 | 18.00M shares 10-Q · filed 2022-03-15 | |
| 2021-10-31 | 19.00M shares 10-Q · filed 2021-12-13 | |
| 2021-07-31 | 20.50M shares 10-Q · filed 2021-09-13 | |
| 2021-04-30 | 19.55M shares 10-K · filed 2022-07-19 | |
| 2020-04-30 | 19.43M shares 10-K · filed 2022-07-19 | |
| 2019-04-30 | 15.71M shares 10-K · filed 2021-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B |